Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

類似資料

• Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
  著者:: Moran, AM, 等
  出版事項: (2020)
• Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
  著者:: Shrimanker, R, 等
  出版事項: (2017)
• Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
  著者:: Charlene Desaintjean, 等
  出版事項: (2024-03-01)
• Glucocorticoids and mepolizumab in eosinophilic asthma.
  著者:: Bel, E, 等
  出版事項: (2014)
• Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
  著者:: Andrea Portacci, 等
  出版事項: (2023-10-01)